PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...

Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million in a lawsuit alleging that ...

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

The long-acting injectable drug for PrEP, cabotegravir, sold under the brand name Apretude, was approved by Health Canada in 2024 to reduce the risk of sexually acquired HIV. The antiretroviral ...

SHIRE, Ethiopia -- The woman survived two brutal attacks in the dying days of the war in Ethiopia’s Tigray region. First, she ...

Let’s look at where HIV treatment is today, the effects new therapies are having, and what treatment may involve in the future. If an antiretroviral drug is successful, it can add many healthy ...

SHIRE, Ethiopia (AP) — The woman survived two brutal attacks in the dying days of the war in Ethiopia’s Tigray region. First, ...

Once a day, Tim Lagman takes a pill that reduces his risk of contracting HIV, a precaution he's taken since 2017. Pre-exposure prophylaxis, or PrEP, is part of the daily routine for a growing ...